Organon & Co. OGN
OGN among the 162 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
OGN and 9 peers, year by year
The 9 Health care companies closest to OGN in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| OGN Organon & Co. | FY2025 | $6.2B | −2.9% | 53.3% | - | 3.0% | 8.7% | 24.9% | 11.52 |
| STE Steris | FY2026 | $5.9B | +8.7% | 44.2% | 18.6% | 13.2% | 16.4% | 10.9% | 0.27 |
| INCY Incyte | FY2025 | $5.1B | +21.2% | - | 29.5% | 25.0% | - | 24.9% | - |
| EHC Encompass Health Corp | FY2025 | $5.9B | +10.5% | - | - | 9.5% | 7.4% | 23.2% | 1.02 |
| OPCH Option Care Health, Inc. | FY2025 | $5.6B | +13.0% | 19.3% | 6.0% | 3.7% | 3.8% | 15.7% | 0.88 |
| RMD ResMed | FY2026 | $5.7B | +9.9% | 61.1% | 33.4% | 26.9% | 29.2% | 23.1% | 0.10 |
| ENSG Ensign Group, Inc | FY2025 | $5.1B | +18.8% | - | 8.4% | 6.8% | - | 15.4% | 0.06 |
| WAT Waters Corporation | FY2025 | $3.2B | +7.0% | - | 25.4% | 20.3% | 17.1% | 25.1% | 0.55 |
| ONC BeOne Medicines Ltd. | FY2025 | $5.3B | +40.2% | 87.5% | 8.4% | 5.4% | 17.6% | 6.6% | 0.19 |
| EW Edwards Lifesciences | FY2025 | $6.1B | +11.5% | 78.0% | 20.8% | 17.7% | 22.0% | 10.4% | 0.06 |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2019 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2019 to FY2025
Revenue as reported in the 10-K.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | $7.8B | $6.5B | $6.3B | $6.2B | $6.3B | $6.4B | $6.2B |
| STE Mar | $2.8B | $3.0B | $3.1B | $4.2B | $4.5B | $5.1B | $5.5B |
| INCY Dec | $2.2B | $2.7B | $3.0B | $3.4B | $3.7B | $4.2B | $5.1B |
| EHC Dec | $4.6B | $3.6B | $4.0B | $4.3B | $4.8B | $5.4B | $5.9B |
| OPCH Dec | $2.3B | $3.0B | $3.4B | $3.9B | $4.3B | $5.0B | $5.6B |
| RMD Jun | $2.6B | $3.0B | $3.2B | $3.6B | $4.2B | $4.7B | $5.1B |
| ENSG Dec | $2.0B | $2.4B | $2.6B | $3.0B | $3.7B | $4.3B | $5.1B |
| WAT Dec | $2.4B | $2.4B | $2.8B | $3.0B | $3.0B | $3.0B | $3.2B |
| ONC Dec | $428.2M | $308.9M | $1.2B | $1.4B | $2.5B | $3.8B | $5.3B |
| EW Dec | $4.3B | $4.4B | $5.2B | $4.5B | $5.0B | $5.4B | $6.1B |
| Peer median | $2.4B | $3.0B | $3.1B | $3.6B | $4.2B | $4.7B | $5.3B |
Sales growth, FY2019 to FY2025
Revenue against the fiscal year before.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | - | −16.0% | −3.5% | −2.1% | +1.4% | +2.2% | −2.9% |
| STE Mar | +6.2% | +8.9% | +2.5% | +47.5% | +7.4% | +13.3% | +6.2% |
| INCY Dec | +14.7% | +23.5% | +12.0% | +13.7% | +8.9% | +14.8% | +21.2% |
| EHC Dec | +7.7% | +0.9% | +12.6% | +8.3% | +10.4% | +11.9% | +10.5% |
| OPCH Dec | +19.1% | +31.3% | +13.4% | +14.7% | +9.1% | +16.2% | +13.0% |
| RMD Jun | +11.4% | +13.4% | +8.1% | +11.9% | +18.0% | +10.9% | +9.8% |
| ENSG Dec | +16.1% | +18.0% | +9.4% | +15.1% | +23.3% | +14.3% | +18.8% |
| WAT Dec | −0.6% | −1.7% | +17.8% | +6.7% | −0.5% | +0.1% | +7.0% |
| ONC Dec | +116% | −27.9% | +281% | +20.4% | +73.7% | +55.0% | +40.2% |
| EW Dec | +16.8% | +0.9% | +19.3% | +2.9% | +12.2% | +8.6% | +11.5% |
| Peer median | +14.7% | +8.9% | +12.6% | +13.7% | +10.4% | +13.3% | +11.5% |
Gross margin, FY2019 to FY2025
Gross profit / revenue.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | - | - | - | 62.8% | 59.8% | 58.0% | 53.3% |
| STE Mar | 42.2% | 43.6% | 43.2% | 44.6% | 43.7% | 43.2% | 44.0% |
| INCY Dec | - | - | - | - | - | - | - |
| EHC Dec | - | - | - | - | - | - | - |
| OPCH Dec | 22.2% | 22.5% | 22.7% | 22.0% | 22.8% | 20.3% | 19.3% |
| RMD Jun | 57.3% | 58.1% | 57.5% | 56.6% | 55.8% | 56.7% | 59.4% |
| ENSG Dec | - | - | - | - | - | - | - |
| WAT Dec | - | - | - | - | - | - | - |
| ONC Dec | - | - | 86.0% | 79.8% | 84.5% | 84.4% | 87.5% |
| EW Dec | 74.4% | 75.4% | 76.1% | 83.8% | 80.5% | 79.5% | 78.0% |
| Peer median | 49.8% | 50.8% | 57.5% | 56.6% | 55.8% | 56.7% | 59.4% |
Operating margin, FY2019 to FY2025
Operating income / revenue.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | - | - | - | - | - | - | - |
| STE Mar | 14.8% | 17.7% | 17.6% | 11.3% | 17.4% | 16.3% | 15.9% |
| INCY Dec | 18.6% | −9.9% | 19.6% | 17.1% | 16.8% | 1.4% | 29.5% |
| EHC Dec | 13.3% | 15.8% | 13.9% | 12.4% | - | - | - |
| OPCH Dec | 0.0% | 3.7% | 5.5% | 6.1% | 7.3% | 6.4% | 6.0% |
| RMD Jun | 22.2% | 27.4% | 28.3% | 28.0% | 26.8% | 28.2% | 32.7% |
| ENSG Dec | 6.3% | 9.3% | 9.9% | 9.8% | 6.8% | 8.4% | 8.4% |
| WAT Dec | 29.4% | 27.3% | 29.5% | 29.4% | 27.7% | 27.9% | 25.4% |
| ONC Dec | −224.2% | −536.7% | −122.3% | −126.4% | −49.1% | −14.9% | 8.4% |
| EW Dec | 26.4% | 20.5% | 32.3% | 33.6% | 26.1% | 25.3% | 20.8% |
| Peer median | 14.8% | 15.8% | 17.6% | 12.4% | 17.1% | 12.3% | 18.4% |
Net margin, FY2019 to FY2025
Net income / revenue.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | 41.4% | 33.1% | 21.4% | 14.9% | 16.3% | 13.5% | 3.0% |
| STE Mar | 10.9% | 13.5% | 12.8% | 5.8% | 2.4% | 7.4% | 11.3% |
| INCY Dec | 20.7% | −11.1% | 31.8% | 10.0% | 16.2% | 0.8% | 25.0% |
| EHC Dec | 7.8% | 8.0% | 10.3% | 6.2% | 7.3% | 8.5% | 9.5% |
| OPCH Dec | −3.3% | −0.3% | 4.1% | 3.8% | 6.2% | 4.2% | 3.7% |
| RMD Jun | 15.5% | 21.0% | 14.8% | 21.8% | 21.3% | 21.8% | 27.2% |
| ENSG Dec | 5.4% | 7.1% | 7.4% | 7.4% | 5.6% | 7.0% | 6.8% |
| WAT Dec | 24.6% | 22.1% | 24.9% | 23.8% | 21.7% | 21.6% | 20.3% |
| ONC Dec | −221.5% | −526.1% | −123.9% | −141.5% | −35.9% | −16.9% | 5.4% |
| EW Dec | 24.1% | 18.8% | 28.7% | 34.1% | 28.0% | 76.7% | 17.7% |
| Peer median | 10.9% | 8.0% | 12.8% | 7.4% | 7.3% | 7.4% | 11.3% |
Free cash flow, FY2019 to FY2025
Cash from operations minus capital spending.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | $2.9B | $2.0B | $2.0B | $662.0M | $548.0M | $764.0M | $538.0M |
| STE Mar | $349.8M | $376.0M | $450.4M | $397.2M | $395.0M | $613.0M | $778.0M |
| INCY Dec | $632.6M | −$312.0M | $568.5M | $892.1M | - | - | - |
| EHC Dec | $262.9M | $311.9M | $191.2M | $141.0M | $267.7M | $360.3M | $439.2M |
| OPCH Dec | $11.2M | $100.5M | $182.9M | $232.2M | $329.4M | $287.8M | $217.1M |
| RMD Jun | $390.3M | $706.9M | $634.0M | $216.3M | $573.6M | $1.3B | $1.7B |
| ENSG Dec | $120.7M | - | - | - | - | - | - |
| WAT Dec | - | - | - | - | $442.2M | $619.6M | $539.8M |
| ONC Dec | −$839.9M | −$1.4B | −$1.6B | −$1.8B | −$1.7B | −$633.3M | $941.7M |
| EW Dec | $928.5M | $647.3M | $1.4B | $973.6M | $642.8M | $289.9M | $1.3B |
| Peer median | $306.3M | $311.9M | $450.4M | $232.2M | $395.0M | $360.3M | $778.0M |
FCF margin, FY2019 to FY2025
Free cash flow / revenue.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | 37.6% | 31.1% | 31.2% | 10.7% | 8.7% | 11.9% | 8.7% |
| STE Mar | 12.6% | 12.4% | 14.5% | 9.4% | 8.7% | 11.9% | 14.3% |
| INCY Dec | 29.3% | −11.7% | 19.0% | 26.3% | - | - | - |
| EHC Dec | 5.7% | 8.7% | 4.8% | 3.2% | 5.6% | 6.7% | 7.4% |
| OPCH Dec | 0.5% | 3.3% | 5.3% | 5.9% | 7.7% | 5.8% | 3.8% |
| RMD Jun | 15.0% | 23.9% | 19.8% | 6.0% | 13.6% | 27.8% | 32.3% |
| ENSG Dec | 5.9% | - | - | - | - | - | - |
| WAT Dec | - | - | - | - | 15.0% | 20.9% | 17.1% |
| ONC Dec | −196.1% | −453.6% | −132.8% | −128.7% | −69.9% | −16.6% | 17.6% |
| EW Dec | 21.4% | 14.8% | 26.9% | 21.8% | 12.8% | 5.3% | 22.0% |
| Peer median | 9.2% | 8.7% | 14.5% | 6.0% | 8.7% | 6.7% | 17.1% |
Return on equity, FY2019 to FY2025
Net income / shareholders' equity at the year end.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | 45.7% | 39.4% | n/m | n/m | n/m | 183.1% | 24.9% |
| STE Mar | 9.6% | 12.0% | 10.2% | 3.7% | 1.8% | 6.0% | 9.3% |
| INCY Dec | 17.2% | −11.3% | 25.2% | 7.8% | 11.5% | 0.9% | 24.9% |
| EHC Dec | 26.5% | 17.9% | 21.6% | 20.7% | 21.4% | 22.0% | 23.2% |
| OPCH Dec | −8.4% | −0.8% | 11.9% | 10.9% | 18.8% | 15.1% | 15.7% |
| RMD Jun | 19.5% | 24.9% | 16.4% | 23.2% | 21.7% | 21.0% | 23.5% |
| ENSG Dec | 16.9% | 20.8% | 19.1% | 18.0% | 14.0% | 16.2% | 15.4% |
| WAT Dec | n/m | n/m | 188.5% | 140.3% | 55.8% | 34.9% | 25.1% |
| ONC Dec | −98.6% | −42.0% | −23.8% | −45.7% | −24.9% | −19.4% | 6.6% |
| EW Dec | 25.2% | 18.0% | 25.8% | 26.2% | 21.1% | 41.8% | 10.4% |
| Peer median | 17.0% | 14.9% | 19.1% | 18.0% | 18.8% | 16.2% | 15.7% |
Debt / equity, FY2019 to FY2025
Total debt / shareholders' equity at the year end.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | - | 0.00 | n/m | n/m | n/m | 18.81 | 11.52 |
| STE Mar | 0.37 | 0.34 | 0.43 | 0.47 | 0.51 | 0.51 | 0.31 |
| INCY Dec | - | - | - | - | - | - | - |
| EHC Dec | 2.26 | 2.07 | 1.72 | 2.11 | 1.65 | 1.21 | 1.02 |
| OPCH Dec | 1.42 | 1.11 | 0.91 | 0.77 | 0.75 | 0.79 | 0.88 |
| RMD Jun | 0.61 | 0.47 | 0.23 | 0.23 | 0.35 | 0.15 | 0.11 |
| ENSG Dec | 0.50 | 0.14 | 0.16 | 0.13 | 0.10 | 0.08 | 0.06 |
| WAT Dec | n/m | 5.86 | 4.14 | 3.13 | 2.05 | 0.89 | 0.55 |
| ONC Dec | 0.09 | 0.22 | 0.10 | 0.12 | 0.25 | 0.56 | 0.19 |
| EW Dec | 0.14 | 0.13 | 0.10 | 0.10 | 0.09 | 0.06 | 0.06 |
| Peer median | 0.50 | 0.40 | 0.33 | 0.35 | 0.43 | 0.53 | 0.25 |
EPS (diluted), FY2019 to FY2025
Diluted earnings per share, on today's share count after splits.
| Company | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| OGN Dec | $12.69 | $8.52 | $5.31 | $3.59 | $3.99 | $3.33 | $0.72 |
| STE Mar | $3.55 | $4.76 | $4.63 | $2.48 | $1.07 | $3.81 | $6.20 |
| INCY Dec | $2.05 | −$1.36 | $4.27 | $1.52 | $2.65 | $0.15 | $6.41 |
| EHC Dec | $3.61 | $2.85 | $4.11 | $2.70 | $3.47 | $4.46 | $5.54 |
| OPCH Dec | −$0.49 | −$0.04 | $0.77 | $0.83 | $1.48 | $1.23 | $1.27 |
| RMD Jun | $2.80 | $4.27 | $3.24 | $5.30 | $6.09 | $6.92 | $9.51 |
| ENSG Dec | $1.97 | $3.06 | $3.42 | $3.95 | $3.65 | $5.12 | $5.84 |
| WAT Dec | $8.69 | $8.36 | $11.17 | $11.73 | $10.84 | $10.71 | $10.76 |
| ONC Dec | −$1.22 | −$1.50 | −$1.21 | −$1.49 | −$0.65 | −$0.47 | $0.19 |
| EW Dec | $1.64 | $1.30 | $2.38 | $2.44 | $2.30 | $6.97 | $1.83 |
| Peer median | $2.05 | $2.85 | $3.42 | $2.48 | $2.65 | $4.46 | $5.84 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out OGN and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: OGN's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OGN/export.csv") into a cell.